It is great news.
It's smart also. Someone at CYP is thinking.
It indicates that the market has gone off Bio and in particular MSC's. Timing is everything.
The market demands revenue now it seems.
The first to approval and revenue wins.
Ann: New Kidney Transplantation Clinical Trial for Cynata & LUMC, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.015(8.82%) |
Mkt cap ! $41.80M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.0¢ | $21.36K | 121.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15599 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 27303 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| CYP (ASX) Chart |